Risk factors for readmission within one year after acute exacerbations of bronchiectasis in a Chinese tertiary hospital: a retrospective cohort study.

IF 2.6 3区 医学 Q2 RESPIRATORY SYSTEM BMC Pulmonary Medicine Pub Date : 2024-12-18 DOI:10.1186/s12890-024-03402-1
Yaxin Fan, Ben Su, Huiyong Zhang, Xiaoyu Yang, Zhengyi Zhang, Shaoyan Zhang, Shunxian Zhang, Dingzhong Wu, Peiyong Zheng, Zhenhui Lu, Lei Qiu
{"title":"Risk factors for readmission within one year after acute exacerbations of bronchiectasis in a Chinese tertiary hospital: a retrospective cohort study.","authors":"Yaxin Fan, Ben Su, Huiyong Zhang, Xiaoyu Yang, Zhengyi Zhang, Shaoyan Zhang, Shunxian Zhang, Dingzhong Wu, Peiyong Zheng, Zhenhui Lu, Lei Qiu","doi":"10.1186/s12890-024-03402-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Frequent exacerbations of bronchiectasis lead to poor quality of life, impaired lung function, and higher mortality rates. This study aims to evaluate the risk factors associated with readmission within one year due to acute exacerbation of bronchiectasis (AEB).</p><p><strong>Methods: </strong>A retrospective cohort study was performed on 260 patients with bronchiectasis who were hospitalized in the respiratory and critical care department of a tertiary hospital in China. Univariate and multivariate Cox analyses were used to evaluate the risk factors for readmission within one year.</p><p><strong>Results: </strong>Readmission within one year was found in 44.6% of 260 patients hospitalized with acute exacerbation of bronchiectasis. The risk factors associated with readmission included age over 65 years (HR = 3.66; 95% CI: 2.30 to 5.85), BMI < 18.5 kg/m<sup>2</sup> (HR = 1.71; 95% CI: 1.16 to 2.51), respiratory intensive care unit (RICU) stay during admission (HR = 2.06, 95% CI: 1.16-3.67), involvement of 3 or more lobes on chest high-resolution computed tomography (HRCT) (HR = 1.85; 95% CI, 1.22 to 2.80), chronic Pseudomonas aeruginosa (PA) colonization (HR = 2.29; 95% CI: 1.54 to 3.38), and positive sputum culture results within 24 h after admission (HR = 1.93; 95% CI: 1.27 to 2.94). Long-term oral antibiotics use after discharge was associated with decreased hazard of readmission (HR = 0.34; 95% CI: 0.20 to 0.59).</p><p><strong>Conclusions: </strong>Patients with bronchiectasis have a high rate of readmission, which is linked to varieties of risk factors, and identifying these risk factors is importance for effectively managing patients with bronchiectasis.</p>","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"24 1","pages":"616"},"PeriodicalIF":2.6000,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11657681/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Pulmonary Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12890-024-03402-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Frequent exacerbations of bronchiectasis lead to poor quality of life, impaired lung function, and higher mortality rates. This study aims to evaluate the risk factors associated with readmission within one year due to acute exacerbation of bronchiectasis (AEB).

Methods: A retrospective cohort study was performed on 260 patients with bronchiectasis who were hospitalized in the respiratory and critical care department of a tertiary hospital in China. Univariate and multivariate Cox analyses were used to evaluate the risk factors for readmission within one year.

Results: Readmission within one year was found in 44.6% of 260 patients hospitalized with acute exacerbation of bronchiectasis. The risk factors associated with readmission included age over 65 years (HR = 3.66; 95% CI: 2.30 to 5.85), BMI < 18.5 kg/m2 (HR = 1.71; 95% CI: 1.16 to 2.51), respiratory intensive care unit (RICU) stay during admission (HR = 2.06, 95% CI: 1.16-3.67), involvement of 3 or more lobes on chest high-resolution computed tomography (HRCT) (HR = 1.85; 95% CI, 1.22 to 2.80), chronic Pseudomonas aeruginosa (PA) colonization (HR = 2.29; 95% CI: 1.54 to 3.38), and positive sputum culture results within 24 h after admission (HR = 1.93; 95% CI: 1.27 to 2.94). Long-term oral antibiotics use after discharge was associated with decreased hazard of readmission (HR = 0.34; 95% CI: 0.20 to 0.59).

Conclusions: Patients with bronchiectasis have a high rate of readmission, which is linked to varieties of risk factors, and identifying these risk factors is importance for effectively managing patients with bronchiectasis.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中国一家三级医院支气管扩张急性加重后一年内再入院的危险因素:一项回顾性队列研究
背景:支气管扩张的频繁恶化导致生活质量差、肺功能受损和更高的死亡率。本研究旨在评估支气管扩张急性加重(AEB)一年内再入院的相关危险因素。方法:对国内某三级医院呼吸重症监护室住院的260例支气管扩张患者进行回顾性队列研究。采用单因素和多因素Cox分析评估一年内再入院的危险因素。结果:260例支气管扩张急性加重住院患者1年内再入院率为44.6%。与再入院相关的危险因素包括:65岁以上(HR = 3.66;95% CI: 2.30 ~ 5.85), BMI 2 (HR = 1.71;95% CI: 1.16 ~ 2.51),住院期间呼吸重症监护病房(RICU) (HR = 2.06, 95% CI: 1.16 ~ 3.67),胸部高分辨率计算机断层扫描(HRCT)累及3个或更多肺叶(HR = 1.85;95% CI, 1.22 - 2.80),慢性铜绿假单胞菌(PA)定植(HR = 2.29;95% CI: 1.54 ~ 3.38),入院后24 h内痰培养阳性(HR = 1.93;95% CI: 1.27 ~ 2.94)。出院后长期口服抗生素与再入院风险降低相关(HR = 0.34;95% CI: 0.20 ~ 0.59)。结论:支气管扩张患者再入院率高,与多种危险因素有关,识别这些危险因素对有效管理支气管扩张患者具有重要意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Pulmonary Medicine
BMC Pulmonary Medicine RESPIRATORY SYSTEM-
CiteScore
4.40
自引率
3.20%
发文量
423
审稿时长
6-12 weeks
期刊介绍: BMC Pulmonary Medicine is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
期刊最新文献
Unsupervised machine learning clustering approach for hospitalized COVID-19 pneumonia patients. Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with chronic lung disease and pulmonary hypertension. Respiratory abnormalities in sarcoidosis: physiopathology and early diagnosis using oscillometry combined with respiratory modeling. Tolerability and efficacy of Mycobacterium avium complex pulmonary disease treatment in elderly patients. A case report of confirmed difficult pulmonary tuberculosis based on the hybrid capture-based tNGS method.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1